Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hyperprolactinemia × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 271 Neoplasms 200 Prostatic Neoplasms 117 Polycystic Ovary Syndrome 114 Colorectal Neoplasms 103 Carcinoma, Hepatocellular 102 Carcinoma, Non-Small-Cell Lung 87 Lung Neoplasms 69 Stomach Neoplasms 62 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Pain 59 Neoplasm Metastasis 53 Multiple Myeloma 51 Keratosis, Actinic 46 Pancreatic Neoplasms 45 Head and Neck Neoplasms 43 Pain, Postoperative 42 Leukemia, Myeloid, Acute 39 Leiomyoma 39 Recurrence 38 Liver Neoplasms 38 Colonic Neoplasms 37 Uterine Cervical Neoplasms 35 Lymphoma 35 Brain Neoplasms 34 Infertility 33 Papillomavirus Infections 32 Ovarian Neoplasms 31 Lymphoma, Follicular 31 Lymphoma, Non-Hodgkin 30

Interventions

Dopamine Agonists 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡